Osteonecrosis of Femoral Head Clinical Trial
Official title:
The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC)
The purposes of the study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in treating osteonecrosis of femoral head patients.
This is a randomized,double-blind, paralleled study. Patients will be divided into two groups of experiment and control. All of them will receive core decompression of the femoral head, while experimental group patient will transplant hUC-MSC in addition. Follow-up visit will occur on 1 month, 3 months, and 6 months after operation, and Harris Hip score was applied to evaluate the symptoms change. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03405974 -
Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip
|
Phase 3 | |
| Recruiting |
NCT04594564 -
Squeaking in Ceramic-on-Ceramic Total Hip Arthroplasty Using Delta TT Cup
|
||
| Completed |
NCT02338596 -
Ultra-Short Anatomic and Conventional Cementless Stems Cementless Stems in Patients Younger Than Fifty-Five Years Old
|
Phase 4 | |
| Recruiting |
NCT04266236 -
LPB Combined With QLB Using Single-needle Technique (LPQLB-SNT) for Hip Arthroplasty
|
N/A | |
| Completed |
NCT02735538 -
Transcription Factor Runx2 in Necrotic Femoral Head Tissue
|
N/A |